Who Buys Ras from India — 2323 Importers Behind a $307.2M Market
India's ras import market is served by 2323 active buyers who collectively imported $307.2M across 15,000 shipments. SUCCESS INTER LINK PTE,LTD (SINGAPORE) leads with a 12.7% market share, followed by MYLAN IRELAND LIMITED and FAWDON MAUFACTURING CENTRE SF. The top 5 buyers together control 25.6% of total import value, reflecting a moderately competitive buyer landscape.
Top Ras Importers — Ranked by Import Value
SUCCESS INTER LINK PTE,LTD (SINGAPORE) is the leading ras importer from India, holding a 12.7% share of the $307.2M market across 15,000 shipments from 2323 buyers. The top 5 buyers — SUCCESS INTER LINK PTE,LTD (SINGAPORE), MYLAN IRELAND LIMITED (NETHERLANDS), FAWDON MAUFACTURING CENTRE SF (UNITED KINGDOM), XXOSIXXLARXXNEWXX LIXXTED (UNITED STATES), FAWDON MAUFACTURING CENTRE (SF) (UNITED KINGDOM) — collectively control 25.6% of total import value.
Top Ras Buyers & Importers
Ranked by import value · 2323 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | SUCCESS INTER LINK PTE,LTDSINGAPORE DUPROST 0.5 MG CAPSULES | $39.1M | 5 | 12.7% |
| 2 | MYLAN IRELAND LIMITEDNETHERLANDS PHARMACEUTICAL DRUGS AND MEDICINE-GRASTOPRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDB | $12.6M | 5 | 4.1% |
| 3 | FAWDON MAUFACTURING CENTRE SFUNITED KINGDOM PHARMA DRUGS & MEDI: PEG FILGRASTIM 6MG/ | $9.2M | 5 | 3.0% |
| 4 | XXOSIXXLARXXNEWXX LIXXTEDUNITED STATES PHARMACEUTICAL DRUGS AND MEDICINE-GRASTOPRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDB | $9.0M | 5 | 2.9% |
| 5 | FAWDON MAUFACTURING CENTRE (SF)UNITED KINGDOM PHARMA DRUGS & MEDI: PEG FILGRASTIM 6MG/ | $8.6M | 5 | 2.8% |
| 6 | MYLAN IRELAND LTDNETHERLANDS PHARMACEUTICAL DRUGS AND MEDICINE-GRASTOPRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDB | $8.0M | 5 | 2.6% |
| 7 | JUTA PHARMA GMBHGERMANY GRASUSTEK INJ 6MG 0 6ML PFS FR ZENTIVAGRASUSTEK INJ 6MG/0.6ML PFS FR ZENTIVA BGRASUSTEK INJ 6MG/0.6ML PFS EU AT-DE BAT | $7.5M | 5 | 2.4% |
| 8 | DR. REDDYS LABORATORIES, INCUNITED STATES PRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDBZIPRASIDONE MESYLATE FOR INJECTION 20MG/VIAL | $6.9M | 5 | 2.2% |
| 9 | TUDO NOVO COMERCIO GERAL LDAANGOLA PHARMACEUTICALS PRODUCTS - PARASEL (25X1PHARMACEUTICALS PRODUCTS- PARASEL(100X10TRASTUREL INJ ( LYOPHILIZED VIAL +20ML S | $6.6M | 5 | 2.2% |
| 10 | MYLAN PHARMACEUTICALS INC,UNITED STATES PHARMACEUTICAL DRUGS AND MEDICINE-GRASTOPRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDB | $6.4M | 5 | 2.1% |
| 11 | ASCEND LABOATORIES,LLC C/O UPSUNITED STATES PRASUGREL TABLETS 10 MG 30BT 104302 PACKSPHARMA DRUGS & MEDI: PEG FILGRASTIM 6MG/FULPHILA PEGFILGRASTIM-JMDB | $5.9M | 5 | 1.9% |
| 12 | FAWDON MANUFACTURING CENTRE SFUNITED KINGDOM PHARMA DRUGS & MEDI: PEG FILGRASTIM 6MG/ | $5.7M | 5 | 1.9% |
| 13 | APOTEX - CANADACANADA PHARMACEUTICAL DRUGS AND MEDICINE-GRASTOPRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDB | $5.4M | 5 | 1.7% |
| 14 | APOTEX CANADACANADA PHARMACEUTICAL DRUGS AND MEDICINE-GRASTOPRASUGREL TABLETS 10 MG 30BT 104302 PACKSFULPHILA PEGFILGRASTIM-JMDB | $5.1M | 5 | 1.7% |
| 15 | FAWDON MANUFACTURING CENTRE ( SF )UNITED KINGDOM PHARMA DRUGS & MEDI: PEG FILGRASTIM 6MG/ | $4.6M | 5 | 1.5% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Ras — and from which countries?
Flow of Ras exports from India: each country's share and the named importers behind the numbers
Ras — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $90.0M through 144 shipments. This represents a market share of 29.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• XXOSIXXLARXXNEWXX LIXXTED - $9.0M (10.0% of country's total business)
• DR. REDDYS LABORATORIES, INC - $6.9M (7.7% of country's total business)
• MYLAN PHARMACEUTICALS INC, - $6.4M (7.1% of country's total business)
• ASCEND LABOATORIES,LLC C/O UPS - $5.9M (6.5% of country's total business)
• ASCEND LABORATORIES LLC - $4.2M (4.6% of country's total business)
• Rest of United States's importers - $57.6M (64.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $625.0K, indicating premium pricing strategy compared to the market average of $20.5K.
United States is a key market for Ras imports, representing 29.3% of total trade value.
2Singapore
Singapore emerges as the second largest importing country, achieving a total trade value of $40.6M through 5 shipments. This represents a market share of 13.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Singapore has a diverse importer base, with their top importers including:
• SUCCESS INTER LINK PTE,LTD - $39.1M (96.2% of country's total business)
Key Insight: Singapore demonstrates strong market positioning with an average shipment value of $8.1M, indicating premium pricing strategy compared to the market average of $20.5K.
Singapore is a key market for Ras imports, representing 13.2% of total trade value.
3United Kingdom
United Kingdom emerges as the third largest importing country, achieving a total trade value of $30.6M through 164 shipments. This represents a market share of 10.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• FAWDON MAUFACTURING CENTRE SF - $9.2M (30.1% of country's total business)
• FAWDON MAUFACTURING CENTRE (SF) - $8.6M (28.2% of country's total business)
• FAWDON MANUFACTURING CENTRE SF - $5.7M (18.8% of country's total business)
• FAWDON MANUFACTURING CENTRE ( SF ) - $4.6M (15.2% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $186.6K, indicating premium pricing strategy compared to the market average of $20.5K.
United Kingdom is a key market for Ras imports, representing 10.0% of total trade value.
4Netherlands
Netherlands emerges as the fourth largest importing country, achieving a total trade value of $24.7M through 211 shipments. This represents a market share of 8.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• MYLAN IRELAND LIMITED - $12.6M (51.1% of country's total business)
• MYLAN IRELAND LTD - $8.0M (32.5% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $116.9K, indicating premium pricing strategy compared to the market average of $20.5K.
Netherlands is a key market for Ras imports, representing 8.0% of total trade value.
5Canada
Canada emerges as the fifth largest importing country, achieving a total trade value of $20.1M through 42 shipments. This represents a market share of 6.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• APOTEX - CANADA - $5.4M (26.6% of country's total business)
• APOTEX CANADA - $5.1M (25.3% of country's total business)
• TARO PHARMACEUTICALS INC., - $4.3M (21.2% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $478.6K, indicating premium pricing strategy compared to the market average of $20.5K.
Canada is a key market for Ras imports, representing 6.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Ras buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for "Ras" imported from India encompasses several key segments:
1. Pharmaceutical Companies: Entities like MYLAN IRELAND LIMITED (Netherlands, $12.61M), FAWDON MANUFACTURING CENTRE SF (United Kingdom, $9.21M), and DR. REDDY'S LABORATORIES, INC (United States, $6.89M) fall into this category. These companies typically procure "Ras" for formulation and distribution within their product lines, often placing large, consistent orders to meet production demands.
2. Distributors and Wholesalers: SUCCESS INTER LINK PTE, LTD (Singapore, $39.10M) exemplifies this segment. Such entities purchase bulk quantities to supply regional markets, maintaining steady order patterns to ensure a continuous supply chain.
3. Contract Manufacturers: Companies like MYLAN IRELAND LTD (Netherlands, $8.03M) and MYLAN PHARMACEUTICALS INC (United States, $6.39M) may also serve as contract manufacturers, producing "Ras" formulations for other brands or markets. Their procurement is aligned with contractual obligations, leading to periodic large-volume purchases.
4. Government Procurement Agencies: Entities such as TUDO NOVO COMERCIO GERAL LDA (Angola, $6.65M) may represent government or public health procurement bodies. These agencies often engage in tender-based purchasing, resulting in substantial, yet less frequent, orders aligned with public health initiatives.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the distinct needs and purchasing behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Ras buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the importation of pharmaceuticals like "Ras" involves specific regulatory processes:
1. United States:
2. Singapore:
3. United Kingdom:
4. Netherlands:
5. Canada:
Compliance with these regulations is essential for market entry and sustained operations within these countries.
Demand Drivers & Market Opportunity
TransData Nexus Ras buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for "Ras" in importing countries is influenced by several factors:
1. Disease Prevalence: "Ras" is commonly used in the treatment of Parkinson's disease. According to the World Health Organization (WHO), the global prevalence of Parkinson's disease has been increasing, with over 10 million people affected worldwide as of 2025. This rising prevalence directly correlates with increased demand for effective treatments like "Ras".
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at providing affordable access to essential medicines. For instance, the United States' Medicare Part D covers prescription drugs, including treatments for chronic conditions like Parkinson's disease. Similarly, the UK's National Health Service (NHS) includes such medications in its formulary, ensuring widespread accessibility.
3. Universal Health Coverage Expansion: Nations are progressively working towards universal health coverage, increasing the accessibility of medications. Canada's healthcare system, for example, provides comprehensive coverage for prescription drugs, facilitating higher consumption rates.
4. WHO Essential Medicines List Procurement: The inclusion of medications like "Ras" in the WHO Essential Medicines List encourages countries to prioritize their procurement, ensuring availability in public health systems.
5. Tender-Based Purchasing: Government and large healthcare organizations often procure pharmaceuticals through tenders, leading to bulk purchasing agreements. This system ensures a steady demand for "Ras" in markets where such procurement processes are prevalent.
With 2,323 buyers across 176 countries, the global reach and consistent demand for "Ras" underscore significant market opportunities, particularly in regions with expanding healthcare access and aging populations.
Common Questions — Ras Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest ras buyer importing from India?
Based on import volume and value, SUCCESS INTER LINK PTE,LTD (SINGAPORE) leads with $39.1M in imports and a 12.7% market share — the highest of any single ras importer. MYLAN IRELAND LIMITED (NETHERLANDS) and FAWDON MAUFACTURING CENTRE SF (UNITED KINGDOM) are the next largest buyers.
QHow many companies buy ras from India?
There are 2323 active ras buyers importing from India, with a combined market of $307.2M across 15,000 shipments to 176 countries. The top 5 buyers hold 25.6% of total import value, while the remaining 2318 buyers handle the other 74.4%.
QWhich countries import the most ras from India?
The top importing countries for ras from India are United States (29.3%), Singapore (13.2%), United Kingdom (10.0%), Netherlands (8.0%), Canada (6.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of ras, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for ras from India?
The average import transaction value for ras from India is $20.5K, with an average unit price of $37.72 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Ras buyer market intelligence
1Buyer Segment Analysis
The buyer landscape for "Ras" imported from India encompasses several key segments:
1. Pharmaceutical Companies: Entities like MYLAN IRELAND LIMITED (Netherlands, $12.61M), FAWDON MANUFACTURING CENTRE SF (United Kingdom, $9.21M), and DR. REDDY'S LABORATORIES, INC (United States, $6.89M) fall into this category. These companies typically procure "Ras" for formulation and distribution within their product lines, often placing large, consistent orders to meet production demands.
2. Distributors and Wholesalers: SUCCESS INTER LINK PTE, LTD (Singapore, $39.10M) exemplifies this segment. Such entities purchase bulk quantities to supply regional markets, maintaining steady order patterns to ensure a continuous supply chain.
3. Contract Manufacturers: Companies like MYLAN IRELAND LTD (Netherlands, $8.03M) and MYLAN PHARMACEUTICALS INC (United States, $6.39M) may also serve as contract manufacturers, producing "Ras" formulations for other brands or markets. Their procurement is aligned with contractual obligations, leading to periodic large-volume purchases.
4. Government Procurement Agencies: Entities such as TUDO NOVO COMERCIO GERAL LDA (Angola, $6.65M) may represent government or public health procurement bodies. These agencies often engage in tender-based purchasing, resulting in substantial, yet less frequent, orders aligned with public health initiatives.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the distinct needs and purchasing behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Ras buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the importation of pharmaceuticals like "Ras" involves specific regulatory processes:
1. United States:
2. Singapore:
3. United Kingdom:
4. Netherlands:
5. Canada:
Compliance with these regulations is essential for market entry and sustained operations within these countries.
Demand Drivers & Market Opportunity
TransData Nexus Ras buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for "Ras" in importing countries is influenced by several factors:
1. Disease Prevalence: "Ras" is commonly used in the treatment of Parkinson's disease. According to the World Health Organization (WHO), the global prevalence of Parkinson's disease has been increasing, with over 10 million people affected worldwide as of 2025. This rising prevalence directly correlates with increased demand for effective treatments like "Ras".
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at providing affordable access to essential medicines. For instance, the United States' Medicare Part D covers prescription drugs, including treatments for chronic conditions like Parkinson's disease. Similarly, the UK's National Health Service (NHS) includes such medications in its formulary, ensuring widespread accessibility.
3. Universal Health Coverage Expansion: Nations are progressively working towards universal health coverage, increasing the accessibility of medications. Canada's healthcare system, for example, provides comprehensive coverage for prescription drugs, facilitating higher consumption rates.
4. WHO Essential Medicines List Procurement: The inclusion of medications like "Ras" in the WHO Essential Medicines List encourages countries to prioritize their procurement, ensuring availability in public health systems.
5. Tender-Based Purchasing: Government and large healthcare organizations often procure pharmaceuticals through tenders, leading to bulk purchasing agreements. This system ensures a steady demand for "Ras" in markets where such procurement processes are prevalent.
With 2,323 buyers across 176 countries, the global reach and consistent demand for "Ras" underscore significant market opportunities, particularly in regions with expanding healthcare access and aging populations.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 2323 global importers of Ras identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 176 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
2323 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists